Effects of the occurrence of a first cardiovascular event on statin adherence in type 2 diabetes: A matched cohort design

F.M. De Vries, P. Denig, S. Vegter, H.J. Bos, M.J. Postma, E. Hak

    Research output: Contribution to journalMeeting AbstractAcademic


    Objectives: Adherence to statin therapy is important for an effective reduction in cardiovascular events. We aimed to assess the effect of the occurrence of a first cardiovascular event on adherence rates in type 2 diabetes patients using a matched cohort design. Methods: A matched cohort study was performed within the IADB. nl pharmacy database among type 2 diabetes patients, who initiated statin treatment for primary prevention. Index patients experienced a first event (index date) after initiation whereas reference patients did not. Index and reference patients were matched on gender, age at statin initiation, statin initiation date, adherence level before the index date and follow-up period. Adherence was measured as percentages of days covered and classified into: non-adherent, partial-adherent or full-adherent. Adherence rates were measured from statin initiation until the index date, and from the index date until end of follow-up, for reference patients in both cases the same follow-up period was used. Mean adherence rates between index and reference before and after were compared by the use of an independent samples T-test. Results: From the 855 index patients 375 could be matched to a reference patient. Mean adherence rates before the index date were 79% for both groups. After the index date, mean adherence rates were 81% for index patients and 71% for reference patients (p-value <0.001). Index patients were more likely to become fulladherent and less likely to become non-adherent. 26% of the index patients used more statins after the event than before whereas 20% used less. Conclusions: Patients receiving a statin are likely to become more adherent after the occurrence of a cardiovascular event during statin treatment. One in five of these patients, however become less adherent showing there are still important health and economic benefits to achieve by tailoring the management of individual patients.
    Original languageEnglish
    Pages (from-to)532-533
    Number of pages2
    JournalValue in Health
    Issue number7
    Publication statusPublished - 1-Nov-2013


    • statin (protein)
    • hydroxymethylglutaryl coenzyme A reductase inhibitor
    • non insulin dependent diabetes mellitus
    • human
    • patient
    • follow up
    • diabetic patient
    • data base
    • Student t test
    • pharmacy
    • cohort analysis
    • gender
    • primary prevention
    • statistical significance
    • health
    • therapy

    Cite this